IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES
1 total filings · 0 classes · Active since Mar 2023
IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 44 (Medical & Beauty Services) with 1 filings. The WikiTrademarks Expansion Score is 1/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed July 24, 2026
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 97867910 | IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES | Mar 31, 2023 | Pending | 044 Medical & Beauty Services | AMICUS THERAPEUTICS, INC. |
Weekly visibility reports showing how ChatGPT mentions IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES trademark portfolio
What trademarks does IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES hold?
IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 44 (Medical & Beauty Services). The most recent filings are registered to AMICUS THERAPEUTICS, INC..
How many trademarks does IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES have at the USPTO?
WikiTrademarks tracks 1 USPTO trademark filings attributed to IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES. The brand has been actively filing since March 2023. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES file most often?
IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES's most active class is NICE Class 44 (Medical & Beauty Services), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES trademark?
The most recent filings under the IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES mark are registered to AMICUS THERAPEUTICS, INC.. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES expanding into new categories?
The current WikiTrademarks Expansion Score for IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES is 1 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES trademark filings?
Click the Watch Brand button at the top of this page to add IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES and help the next person researching it.